// App-Quantinova.ai

P3-11-17 : Statins suppress the aggressive phenotype of triple negative breast cancer cells via modulation of EGFR signalling

Researchers

Presenter

  • Chris Smith

Principal Investigators

  • Shafila Alim

  • Aliki Kadi

  • Ruba Al Lawati

  • Madeline Miles

  • Steve Hiscox

Medical Centers

  • Cardiff University, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • Proliferation marker protein Ki-67

  • Epidermal growth factor receptor

Drug/Treatment

  • Atorvastatin

  • Rosuvastatin

  • Simvastatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved